
Lexicon Pharmaceuticals and Bristol-Myers Squibb launch drug discovery alliance.

Lexicon Pharmaceuticals and Bristol-Myers Squibb launch drug discovery alliance.

Top news of the day from across the health care landscape.

Only 13% of patients taking opioids for low back pain said the treatment was very successful.

Patients insured through Medicaid experienced high levels of pain in the post anesthesia care unit.

How can you help a patient prepare for the additional medication costs and lifestyle challenges he may be facing?

Melatonin: it's more than just a sleep aid.

New research highlights the need for earlier access to effective pain medications among advanced cancer patients.

Meperidine was synthetically derived in 1939 as an anticholinergic agent, but was discovered to possess analgesic properties shortly after.

Ointment shows promise preventing neuropathy.

Community pharmacists are frontline providers in helping patients control and manage acute and chronic pain.

Complementary health approaches for managing pain conditions may reduce opioid prescriptions.

Morphine tolerance found to be caused by an inflammatory response in the brain.

The drug PZM21 could potentially provide pain relief without addiction risk.

Ankylosing spondylitis is a complex, painful condition that can affect many parts of your body.

Ankylosing spondylitis is a complex, painful condition that can affect many parts of your body.

A significant proportion of patients with fibromyalgia also suffer from depression and anxiety, according to the results of a recent study.

A recent study has determined that the use of hyperbaric oxygen chambers, in which patients are exposed to pure oxygen at higher-than-atmospheric pressures, may be able to relieve fibromyalgia pain.

Although fibromyalgia pain can prove difficult to manage, recent study results suggest that individually tailored acupuncture can reduce the intensity of pain experienced by patients with this condition.

As computational techniques become more sophisticated, the idea of targeted therapeutic treatments sans adverse effects could become reality.

Although their pharmacokinetics are all similar, here's how they differ.

Which OTC products should these pharmacists recommend?

Substance P can lessen pain response in the peripheral nervous system.

Top news of the day from across the healthcare landscape.

Individuals with moderate or severe pain more likely to develop a prescription opioid use disorder.

Multiple types of spinal cord stimulation could be used to treat chronic back and limb pain.